Safety and Bioavailability of IV and SC LBR-101
- Study Title
- Safety and Bioavailability of IV and SC LBR-101
- Teva Identifier
- LBR-101-011
- ClinicalTrials.gov Identifier
- NCT01991509
- Study Status
- Completed
- Trial Condition(s)
- Bioavailability and Pharmacokinetics
- Interventions
- Biological: LBR-101 IV | Biological: LBR-101 SC
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 60 Years
- Trial Duration
- 10/01/2013 - 01/01/2015
- Phase
- Phase 1
